Your browser doesn't support javascript.
loading
Level of Asthma Controller Therapy Before Admission to the Hospital.
Belhassen, Manon; Langlois, Carole; Laforest, Laurent; Dima, Alexandra Lelia; Ginoux, Marine; Sadatsafavi, Mohsen; Van Ganse, Eric.
Afiliação
  • Belhassen M; PELyon, Lyon, France; HESPER 7425, Health Services and Performance Research, Lyon, France. Electronic address: manon.belhassen@univ-lyon1.fr.
  • Langlois C; PELyon, Lyon, France; HESPER 7425, Health Services and Performance Research, Lyon, France.
  • Laforest L; PELyon, Lyon, France; HESPER 7425, Health Services and Performance Research, Lyon, France.
  • Dima AL; Department of Communication Science, ASCoR, University of Amsterdam, Amsterdam, The Netherlands.
  • Ginoux M; PELyon, Lyon, France; HESPER 7425, Health Services and Performance Research, Lyon, France.
  • Sadatsafavi M; Institute for Heart and Lung Health, Department of Medicine, The University of British Columbia, Vancouver, Canada; Centre for Clinical Epidemiology and Evaluation, The University of British Columbia, Vancouver, Canada.
  • Van Ganse E; PELyon, Lyon, France; HESPER 7425, Health Services and Performance Research, Lyon, France; Respiratory Medicine, Croix Rousse University Hospital, Lyon, France.
J Allergy Clin Immunol Pract ; 4(5): 877-83, 2016.
Article em En | MEDLINE | ID: mdl-27452886
ABSTRACT

BACKGROUND:

In asthma, choice of controller therapy and adherence to treatment can affect the risk of future severe exacerbations leading to hospitalization.

OBJECTIVE:

Our objective was to characterize treatment dispensation profiles before hospital admission for asthma.

METHODS:

Using a 1/97th random sample of the national French claims data, patients with asthma aged 6 to 40 years were identified between 2006 and 2014. Patients with subsequent asthma-related hospitalization were selected. On the basis of controller therapy dispensed in the 12 months before admission, treatment profiles were categorized into clusters, using Ward's minimum-variance hierarchical clustering method.

RESULTS:

Of 17,846 patients with asthma, we identified 275 patients (1.5%) with an asthma-related hospitalization. Three distinct clusters were identified. The first cluster (63.6%) included patients with few dispensations of any controller medication (<1 unit). The second cluster (32.4%) consisted of patients with frequent dispensations of long-acting beta agonists (LABAs)/inhaled corticosteroids (ICS) in fixed-dose combinations. The third cluster (4%) comprised patients receiving free combinations of ICS and LABAs, with more dispensations of LABAs than of ICS.

CONCLUSIONS:

In France, before an asthma-related hospitalization, more than 60% of patients received little controller therapy and 4% were exposed to higher dispensation of LABAs than of ICS. These results indicate that a large fraction of asthma-related hospitalizations can potentially be prevented with better pharmacotherapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prescrições de Medicamentos / Asma / Antiasmáticos / Hospitalização Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prescrições de Medicamentos / Asma / Antiasmáticos / Hospitalização Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article